Pedro O. de Campos‐Lima

1.4k total citations
35 papers, 1.2k citations indexed

About

Pedro O. de Campos‐Lima is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Pedro O. de Campos‐Lima has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 16 papers in Immunology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Pedro O. de Campos‐Lima's work include Viral-associated cancers and disorders (13 papers), Immune Cell Function and Interaction (12 papers) and Lymphoma Diagnosis and Treatment (7 papers). Pedro O. de Campos‐Lima is often cited by papers focused on Viral-associated cancers and disorders (13 papers), Immune Cell Function and Interaction (12 papers) and Lymphoma Diagnosis and Treatment (7 papers). Pedro O. de Campos‐Lima collaborates with scholars based in Canada, Sweden and Brazil. Pedro O. de Campos‐Lima's co-authors include Maria G. Masucci, Riccardo Gavioli, Alan B. Rickinson, Riccardo Dolcetti, Lesley E. Wallace, Victor Levitsky, Manuel Caruso, Michael G. Kurilla, Qian-Jin Zhang and Martin Rowe and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Pedro O. de Campos‐Lima

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro O. de Campos‐Lima Canada 16 611 550 293 235 201 35 1.2k
Jerome E. Tanner Canada 19 581 1.0× 944 1.7× 530 1.8× 381 1.6× 262 1.3× 34 1.7k
Fuliang Chu United States 19 1.4k 2.2× 386 0.7× 112 0.4× 191 0.8× 310 1.5× 39 2.0k
Sumita Bhaduri‐McIntosh United States 21 384 0.6× 625 1.1× 374 1.3× 175 0.7× 488 2.4× 51 1.2k
Margaret K. Offermann United States 21 569 0.9× 643 1.2× 527 1.8× 165 0.7× 318 1.6× 34 1.4k
Karen Duus United States 22 545 0.9× 229 0.4× 348 1.2× 115 0.5× 284 1.4× 34 1.3k
David Ghez France 21 541 0.9× 395 0.7× 247 0.8× 327 1.4× 241 1.2× 81 1.4k
Teresa Y. Basham United States 17 1.0k 1.7× 249 0.5× 217 0.7× 195 0.8× 303 1.5× 28 1.6k
Maria Teresa Bejarano Sweden 16 484 0.8× 510 0.9× 190 0.6× 257 1.1× 126 0.6× 25 969
Olivier Manches France 21 1.2k 2.0× 420 0.8× 192 0.7× 168 0.7× 345 1.7× 44 1.8k
Gretchen L. Bentz United States 18 582 1.0× 441 0.8× 735 2.5× 128 0.5× 538 2.7× 20 1.5k

Countries citing papers authored by Pedro O. de Campos‐Lima

Since Specialization
Citations

This map shows the geographic impact of Pedro O. de Campos‐Lima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro O. de Campos‐Lima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro O. de Campos‐Lima more than expected).

Fields of papers citing papers by Pedro O. de Campos‐Lima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro O. de Campos‐Lima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro O. de Campos‐Lima. The network helps show where Pedro O. de Campos‐Lima may publish in the future.

Co-authorship network of co-authors of Pedro O. de Campos‐Lima

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro O. de Campos‐Lima. A scholar is included among the top collaborators of Pedro O. de Campos‐Lima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro O. de Campos‐Lima. Pedro O. de Campos‐Lima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Sylvie, Karim Ghani, Pedro O. de Campos‐Lima, & Manuel Caruso. (2021). A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein. Virus Research. 295. 198305–198305. 14 indexed citations
2.
Nowill, Alexandre E. & Pedro O. de Campos‐Lima. (2020). Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2–Induced Cytokine Storm. The Journal of Immunology. 205(10). 2566–2575. 12 indexed citations
3.
Chicaybam, Leonardo, Bárbara Peixoto, Angelo B. A. Laranjeira, et al.. (2019). CAR T Cells Generated Using Sleeping Beauty Transposon Vectors and Expanded with an EBV-Transformed Lymphoblastoid Cell Line Display Antitumor Activity In Vitro and In Vivo. Human Gene Therapy. 30(4). 511–522. 21 indexed citations
4.
Zenatti, Priscila Pini, et al.. (2018). Low Bioavailability and High Immunogenicity of a New Brand of E. coli l-Asparaginase with Active Host Contaminating Proteins. EBioMedicine. 30. 158–166. 32 indexed citations
5.
Ghani, Karim, et al.. (2013). The Size of the Unbranched Aliphatic Chain Determines the Immunomodulatory Potency of Short and Long Chain n-Alkanols. Journal of Biological Chemistry. 288(34). 24948–24955. 9 indexed citations
6.
Campos‐Lima, Pedro O. de, et al.. (2012). Short-term immunological effects of non-ethanolic short-chain alcohols. Toxicology Letters. 210(1). 44–52. 6 indexed citations
7.
8.
9.
Cottin, Sylvine Carrondo, Karim Ghani, Pedro O. de Campos‐Lima, & Manuel Caruso. (2010). Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy. Molecular Cancer. 9(1). 141–141. 31 indexed citations
10.
Ghani, Karim, Sylvine Carrondo Cottin, Pedro O. de Campos‐Lima, Marie‐Christine Caron, & Manuel Caruso. (2009). Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery. The Journal of Gene Medicine. 11(8). 664–669. 4 indexed citations
11.
12.
Avila‐Cariño, Javier, et al.. (2007). Rescue of the immunotherapeutic potential of a novel T cell epitope in the Epstein–Barr virus latent membrane protein 2. Virology. 361(2). 253–262. 7 indexed citations
13.
Roy, Vincent, Jie Qiao, Pedro O. de Campos‐Lima, & Manuel Caruso. (2004). Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase. Gene Therapy. 12(2). 169–176. 12 indexed citations
14.
Germain, Emmanuelle, Gaëlle Roullin, Jing Qiao, Pedro O. de Campos‐Lima, & Manuel Caruso. (2004). RD114‐pseudotyped retroviral vectors kill cancer cells by syncytium formation and enhance the cytotoxic effect of the TK/GCV gene therapy strategy. The Journal of Gene Medicine. 7(4). 389–397. 7 indexed citations
15.
Imreh, Márta P., Pedro O. de Campos‐Lima, Stephan Imreh, et al.. (1995). Mechanisms of allele‐selective down‐regulation of HLA class I in Burkitt's lymphoma. International Journal of Cancer. 62(1). 90–96. 24 indexed citations
16.
Wendel‐Hansen, Vidar, Johan Sällström, Pedro O. de Campos‐Lima, et al.. (1994). Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.. PubMed. 8(3). 476–84. 51 indexed citations
17.
Campos‐Lima, Pedro O. de, Victor Levitsky, Jill Brooks, et al.. (1994). T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.. The Journal of Experimental Medicine. 179(4). 1297–1305. 139 indexed citations
18.
Masucci, Maria G., et al.. (1993). Transformation‐Associated Epstein‐Barr Virus Antigens as Targets for Immune Attacka. Annals of the New York Academy of Sciences. 690(1). 86–100. 7 indexed citations
19.
Trivedi, Pankaj, Laura Cuomo, Pedro O. de Campos‐Lima, et al.. (1993). Integration of a short Epstein--Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein--Barr nuclear antigens EBNA2 and EBNA5. Journal of General Virology. 74(7). 1393–1398. 6 indexed citations
20.
Campos‐Lima, Pedro O. de, Sigurbjörg Torsteinsdóttir, Laura Cuomo, et al.. (1993). Antigen processing and presentation by EBV‐carrying cell lines: Cell‐phenotype dependence and influence of the EBV‐encoded LMP1. International Journal of Cancer. 53(5). 856–862. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerome E. Tanner Breakdown of academic impact, for papers by Fuliang Chu Breakdown of academic impact, for papers by Sumita Bhaduri‐McIntosh Breakdown of academic impact, for papers by Margaret K. Offermann Breakdown of academic impact, for papers by Karen Duus Breakdown of academic impact, for papers by David Ghez Breakdown of academic impact, for papers by Teresa Y. Basham Breakdown of academic impact, for papers by Maria Teresa Bejarano Breakdown of academic impact, for papers by Olivier Manches Breakdown of academic impact, for papers by Gretchen L. Bentz
Rankless by CCL
2026